BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29478746)

  • 1. Methylphenidate alters monoaminergic and metabolic pathways in the cerebellum of adolescent rats.
    Quansah E; Ruiz-Rodado V; Grootveld M; Zetterström TSC
    Eur Neuropsychopharmacol; 2018 Apr; 28(4):513-528. PubMed ID: 29478746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum.
    Quansah E; Zetterström TSC
    Neurochem Int; 2019 Mar; 124():193-199. PubMed ID: 30660754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of developmental methylphenidate (MPH) treatment on monoamine neurochemistry of male and female rats.
    Panos JJ; O'Callaghan JP; Miller DB; Ferguson SA
    Neurotoxicol Teratol; 2014; 45():70-4. PubMed ID: 25132048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate increases glucose uptake in the brain of young and adult rats.
    Réus GZ; Scaini G; Titus SE; Furlanetto CB; Wessler LB; Ferreira GK; Gonçalves CL; Jeremias GC; Quevedo J; Streck EL
    Pharmacol Rep; 2015 Oct; 67(5):1033-40. PubMed ID: 26398400
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Quansah E; Ruiz-Rodado V; Grootveld M; Probert F; Zetterström TSC
    Neurochem Int; 2017 Sep; 108():109-120. PubMed ID: 28268188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic methylphenidate regulates genes and proteins mediating neuroplasticity in the juvenile rat brain.
    Quansah E; Sgamma T; Jaddoa E; Zetterström TSC
    Neurosci Lett; 2017 Jul; 654():93-98. PubMed ID: 28633952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats.
    Gomes KM; Inácio CG; Valvassori SS; Réus GZ; Boeck CR; Dal-Pizzol F; Quevedo J
    Neurosci Lett; 2009 Nov; 465(1):95-8. PubMed ID: 19716398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates.
    Zhang X; Talpos J; Berridge MS; Apana SM; Slikker W; Wang C; Paule MG
    Neurotoxicol Teratol; 2021; 87():107017. PubMed ID: 34265415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro.
    Bartl J; Palazzesi F; Parrinello M; Hommers L; Riederer P; Walitza S; Grünblatt E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):281-288. PubMed ID: 28690202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute and chronic methylphenidate on delay discounting.
    Slezak JM; Anderson KG
    Pharmacol Biochem Behav; 2011 Oct; 99(4):545-51. PubMed ID: 21669219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of methylphenidate after long-term exposure in nonhuman primates.
    Zhang X; Berridge MS; Apana SM; Slikker W; Paule MG; Talpos J
    Neurotoxicol Teratol; 2023; 97():107173. PubMed ID: 36893929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability.
    Markowitz JS; Zhu HJ; Patrick KS
    J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):648-54. PubMed ID: 24261661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate alters NCS-1 expression in rat brain.
    Souza RP; Soares EC; Rosa DV; Souza BR; Réus GZ; Barichello T; Gomes KM; Gomez MV; Quevedo J; Romano-Silva MA
    Neurochem Int; 2008 Jul; 53(1-2):12-6. PubMed ID: 18514368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
    Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors.
    Rozas C; Carvallo C; Contreras D; Carreño M; Ugarte G; Delgado R; Zeise ML; Morales B
    Neuropharmacology; 2015 Dec; 99():15-27. PubMed ID: 26165920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
    Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.
    Cheng J; Xiong Z; Duffney LJ; Wei J; Liu A; Liu S; Chen GJ; Yan Z
    Biol Psychiatry; 2014 Dec; 76(12):953-62. PubMed ID: 24832867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.